• No results found

Sensory Predominant Chronic Inflammatory Demyelinating Polyneuropathy (SP-CIDP)

Diagnostics of Sensory Ataxia in Patients with Sensory Predominant Chronic Inflammatory Demyelinating Polyneuropathy from Republic of Sakha (Yakutia) and Krasnoyarsk Region

Diagnostics of Sensory Ataxia in Patients with Sensory Predominant Chronic Inflammatory Demyelinating Polyneuropathy from Republic of Sakha (Yakutia) and Krasnoyarsk Region

... activity chronic peripheral polyneuropathies, including sensory predominant chronic inflammatory demyelinating polyneuropathy ...motor SP-CIDP disorders is ...

10

Cost-utility of Intravenous Immunoglobulin (IVIG) compared with corticosteroids for the treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Canada

Cost-utility of Intravenous Immunoglobulin (IVIG) compared with corticosteroids for the treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Canada

... CIDP has both motor and sensory symptoms, with motor being the predominant feature. There is symmetri- cal involvement of both arms and legs, including both proximal and distal muscles, resulting in ...

9

Isolated unilateral palatal and vocal cord palsy as an initial presentation of chronic inflammatory demyelinating polyradiculoneuropathy

Isolated unilateral palatal and vocal cord palsy as an initial presentation of chronic inflammatory demyelinating polyradiculoneuropathy

... of inflammatory cells in more than half in- dividuals [3, ...include sensory-motor, symmetrical polyneuropathy, predom- inantly distal features, exclusively sensory signs and symptoms, ...

5

Pathway construction of chronic inflammatory demyelinating polyneuropathy (CIPD): a neurodegenerative disease

Pathway construction of chronic inflammatory demyelinating polyneuropathy (CIPD): a neurodegenerative disease

... It helps in predicting the function of the desired genes and sets of gene. It finds other genes that are related to the set of input genes, using a very large set of functional association data. The association data ...

7

Child Neurology: Chronic inflammatory demyelinating polyradiculoneuropathy in children

Child Neurology: Chronic inflammatory demyelinating polyradiculoneuropathy in children

... Differential diagnosis. In the evaluation of gait difficulty, as with other neurologic complaints, localization based on history and physical examination is the first step. The decreased tendon reflexes, flexor plantar ...

6

A study of Peripheral Neuropathy in HIV infected patients.

A study of Peripheral Neuropathy in HIV infected patients.

... the sensory loss follow a stocking-glove (distal predominate), dermatomal, or radicular pattern? The sensory examination frequently focuses on determining whether there is “large fiber” or “small fiber” ...

110

Observer blind randomised controlled trial of a tailored home exercise programme versus usual care in people with stable inflammatory immune mediated neuropathy

Observer blind randomised controlled trial of a tailored home exercise programme versus usual care in people with stable inflammatory immune mediated neuropathy

... acute inflammatory polyneuropathy, characterised by rapidly progressive weakness, paralysis and sensory im- pairment reaching nadir within four weeks of onset [2] such that the majority of patients ...

9

Overview of the pathogenesis and treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulins

Overview of the pathogenesis and treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulins

... Abstract: Chronic inflammatory demyelinating polyneuropathy (CIDP) is an acquired hetero- geneous disorder of immune origin affecting the peripheral nerves, causing motor weakness and ...

5

A REVIEW ON PATHOGENESIS AND TREATMENT OF DIABETIC NEUROPATHY

A REVIEW ON PATHOGENESIS AND TREATMENT OF DIABETIC NEUROPATHY

... mimic chronic inflammatory demyelinating polyneuropathy, alcoholic neuropathy, and other endocrine neuropathies, hence, before labelling diabetic neuropathy it is mandatory to exclude all ...

13

Neurofascin antibodies in autoimmune, genetic, and idiopathic neuropathies

Neurofascin antibodies in autoimmune, genetic, and idiopathic neuropathies

... with CIDP found 5 patients (2%) with IgG4-predominant responses to the common epitopes of NF140, NF186, and ...prominent sensory ataxia, and sometimes cranial nerve in- ...with CIDP, so ...

10

Autonomic dysfunction in chronic inflammatory demyelinating polyneuropathy.

Autonomic dysfunction in chronic inflammatory demyelinating polyneuropathy.

... having CIDP. Approximately 90% of patients with CIDP have elevated CSF protein concentrations (> 45 mg ...of CIDP cannot be excluded based on a normal CSF protein ...

92

A Case of Acquired Chronic Inflammatory Demyelinating Polyneuropathy

A Case of Acquired Chronic Inflammatory Demyelinating Polyneuropathy

... symptoms were successfully managed on both presentation but her diagnosis, remain unclear. Due to absence of contrasting features on presentation, the initial diagnosis of the patient was unclear. After a course of IVIG, ...

8

Novel insight into Chronic Inflammatory Demyelinating Polineuropathy in APECED syndrome: molecular mechanisms and clinical implications in children

Novel insight into Chronic Inflammatory Demyelinating Polineuropathy in APECED syndrome: molecular mechanisms and clinical implications in children

... A key question in autoimmune disease is the identity of inciting antigens. This question has been particularly difficult to address in CIDP because only a minority of patient sera samples contain PNS ...

5

Novel pathomechanisms in inflammatory neuropathies

Novel pathomechanisms in inflammatory neuropathies

... in demyelinating human GBS remains ...of demyelinating GBS patients [50 – ...some demyelinating GBS cases ...of demyelinating GBS patients and no corresponding microbial structure with ...

17

Quantitative grip force assessment of muscular weakness in chronic inflammatory demyelinating polyneuropathy

Quantitative grip force assessment of muscular weakness in chronic inflammatory demyelinating polyneuropathy

... from Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) disease severity is assessed by Medical Research Counsil (MRC) Scale or Inflammatory Neuropathy Cause and Treatment ...

9

Neutrophil–lymphocyte ratio and response to plasmapheresis in Guillain–Barré syndrome: a prospective observational study

Neutrophil–lymphocyte ratio and response to plasmapheresis in Guillain–Barré syndrome: a prospective observational study

... To evaluate the therapeutic role of plasmapheresis in GBS and its relation to NLR, we found that the cut-off value for the NLR for predicting response to plasma- pheresis in GBS was ≤ 4.4 with 81.5% sensitivity and 87.5% ...

6

Clinical and electrophysiological features of post-traumatic Guillain-Barré syndrome

Clinical and electrophysiological features of post-traumatic Guillain-Barré syndrome

... illness polyneuropathy. In these patients the degree of sensory symptoms and sensory nerve involvement tends to be ...illness polyneuropathy does not generally respond to IVIG and/ or plasma ...

7

Acute paretic syndrome in juvenile White Leghorn chickens resembles late stages of acute inflammatory demyelinating polyneuropathies in humans

Acute paretic syndrome in juvenile White Leghorn chickens resembles late stages of acute inflammatory demyelinating polyneuropathies in humans

... A drawback of AvIDP as a disease model lays in the difficulty to identify pre- or subclinical animals and thereby the very early stages of immunopathology, before switching from Th1- to Th2-mediated cascades. However, ...

20

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial

... a CIDP relapse during the SC treatment period received, within 1 week, IgPro10 as IVIg rescue medication (2 g/kg bw) and underwent a completion visit before the start of the rescue ...

39

Autonomic Dysfunction in Iraqi Patients with Chronic Inflammatory Demyelinating Polyneuropathy

Autonomic Dysfunction in Iraqi Patients with Chronic Inflammatory Demyelinating Polyneuropathy

... acquired demyelinating sensory and motor neuropathy [the Lewis–Sumner syndrome]has similarities to both chronic inflammatory demyelinating polyneuropathy ...and sensory ...

9

Show all 10000 documents...

Related subjects